Figure 2.

Associations between history of asthma with and without medication use and outcomes following COVID-19 diagnosis. All models are adjusted for age group, gender, race/ethnicity, income, college education, Medicaid insurance status, body mass index (BMI) category, smoking, and modified Charlson comorbidity score. Asthma patients were categorized as active asthma if they had a clinical visit for asthma in the 12 mo prior to COVID-19 diagnosis, and as inactive asthma if otherwise. For death, the measure of association is the hazard ratio (HR) from the Cox model.